These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8733063)
1. Different origins of mutations at the Machado-Joseph locus (MJD1). Iughetti P; Zatz M; Bueno MR; Marie SK J Med Genet; 1996 May; 33(5):439. PubMed ID: 8733063 [No Abstract] [Full Text] [Related]
2. Characterisation of the unstable expanded CAG repeat in the MJD1 gene in four Brazilian families of Portuguese descent with Machado-Joseph disease. Stevanin G; Cassa E; Cancel G; Abbas N; Dürr A; Jardim E; Agid Y; Sousa PS; Brice A J Med Genet; 1995 Oct; 32(10):827-30. PubMed ID: 8558567 [TBL] [Abstract][Full Text] [Related]
10. Regional and cellular expression of the Machado-Joseph disease gene in brains of normal and affected individuals. Nishiyama K; Murayama S; Goto J; Watanabe M; Hashida H; Katayama S; Nomura Y; Nakamura S; Kanazawa I Ann Neurol; 1996 Nov; 40(5):776-81. PubMed ID: 8957019 [TBL] [Abstract][Full Text] [Related]
11. Homozygous Machado Joseph Disease: a case report and review of literature. Lysenko L; Grewal RP; Ma W; Peddareddygari LR Can J Neurol Sci; 2010 Jul; 37(4):521-3. PubMed ID: 20724264 [No Abstract] [Full Text] [Related]
12. Variation in the number of CAG repeats in the Machado-Joseph disease gene (MJD1) in the Japanese population. Matsuyama Z; Kawakami H; Maruyama H; Harada H; Nakata K; Yamaguchi Y; Nakamura S J Neurol Sci; 1999 Jun; 166(1):71-3. PubMed ID: 10465503 [TBL] [Abstract][Full Text] [Related]
13. Pathological crying in patients with Machado-Joseph disease. Guimarães J; Bugalho P; Coutinho P Mov Disord; 2008 Feb; 23(3):470-1. PubMed ID: 18098278 [No Abstract] [Full Text] [Related]
14. [Mechanisms to control degradation of polyglutamine-containing protein]. Nakayama K Rinsho Shinkeigaku; 2003 Nov; 43(11):906-8. PubMed ID: 15152500 [TBL] [Abstract][Full Text] [Related]
15. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3? Alves S; Nascimento-Ferreira I; Dufour N; Hassig R; Auregan G; Nóbrega C; Brouillet E; Hantraye P; Pedroso de Lima MC; Déglon N; de Almeida LP Hum Mol Genet; 2010 Jun; 19(12):2380-94. PubMed ID: 20308049 [TBL] [Abstract][Full Text] [Related]
16. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Ikeda H; Yamaguchi M; Sugai S; Aze Y; Narumiya S; Kakizuka A Nat Genet; 1996 Jun; 13(2):196-202. PubMed ID: 8640226 [TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A for treatment of spasticity in spinocerebellar ataxia type 3 (Machado-Joseph disease). Freeman W; Wszolek Z Mov Disord; 2005 May; 20(5):644. PubMed ID: 15747361 [No Abstract] [Full Text] [Related]
18. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Kawaguchi Y; Okamoto T; Taniwaki M; Aizawa M; Inoue M; Katayama S; Kawakami H; Nakamura S; Nishimura M; Akiguchi I Nat Genet; 1994 Nov; 8(3):221-8. PubMed ID: 7874163 [TBL] [Abstract][Full Text] [Related]
19. Study of three intragenic polymorphisms in the Machado-Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)n tract. Maciel P; Gaspar C; Guimarães L; Goto J; Lopes-Cendes I; Hayes S; Arvidsson K; Dias A; Sequeiros J; Sousa A; Rouleau GA Eur J Hum Genet; 1999; 7(2):147-56. PubMed ID: 10196697 [TBL] [Abstract][Full Text] [Related]
20. Non-Mendelian transmission at the Machado-Joseph disease locus in normal females: preferential transmission of alleles with smaller CAG repeats. Rubinsztein DC; Leggo J J Med Genet; 1997 Mar; 34(3):234-6. PubMed ID: 9132496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]